BiotechTube
Home/Pipeline/modEXO Platform Programs

modEXO Platform Programs

Oncology and inflammatory diseases (liver, pulmonary, digestive system)

PreclinicalActive

Key Facts

Indication
Oncology and inflammatory diseases (liver, pulmonary, digestive system)
Phase
Preclinical
Status
Active
Company
VesiCURE Therapeutics

About VesiCURE Therapeutics

A Chinese biotech company developing engineered exosome drug delivery platforms for oncology and inflammatory diseases.

View full company profile

Therapeutic Areas

OncologyRegenerative MedicineDrug Delivery